Svedberg, Anna; Björn, Niclas; Sigurgeirsson, Benjamín; Pradhananga, Sailendra; Brandén, Eva; Koyi, Hirsh; Lewensohn, Rolf; De Petris, Luigi; Apellániz-Ruiz, María; Rodríguez-Antona, Cristina; Lundeberg, Joakim; Gréen, Henrik
(Elsevier BV, 2020-09)
Objectives: Gemcitabine/carboplatin treatment is known to cause severe adverse drug reactions which can lead to the need for reduction or cessation of chemotherapy. It would be beneficial to identify patients at risk of severe hematological toxicity ...